Susan MOODY

Person

Cambridge, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Dosing schedule of a Wnt inhibitor and an anti-PD-1 antibody molecu...
- Patent number 11,406,633
- Issue date Aug 9, 2022
- Jason Russell Dobson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF MPNST
- Publication number 20240238284
- Publication date Jul 18, 2024
- Novartis AG
- Huaixiang HAO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMBINATION COMPRISING TNO155 AND NAZARTINIB
- Publication number 20230172928
- Publication date Jun 8, 2023
- Novartis AG
- Huaixiang HAO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Dosing schedule of a Wnt inhibitor and an anti-PD-1 antibody molecu...
- Publication number 20230063366
- Publication date Mar 2, 2023
- Novartis AG
- Jason Russell DOBSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEW THERAPEUTIC USES
- Publication number 20210145842
- Publication date May 20, 2021
- Novartis AG
- Susan Elizabeth MOODY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC COMBINATION OF A THIRD-GENERATION EGFR TYROSINE KINASE...
- Publication number 20200237773
- Publication date Jul 30, 2020
- Novartis AG
- Susan Moody
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC COMBINATION OF A THIRD GENERATION EGFR TYROSINE KINASE...
- Publication number 20200155566
- Publication date May 21, 2020
- Novartis AG
- Susan Moody
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DOSING SCHEDULE OF A WNT INHIBITOR AND AN ANTI-PD-1 ANTIBODY MOLECU...
- Publication number 20190365746
- Publication date Dec 5, 2019
- Novartis AG
- Jason Russell DOBSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Susan MOODY

Person

Patents Grantslast 30 patents

Dosing schedule of a Wnt inhibitor and an anti-PD-1 antibody molecu...

Patents Applicationslast 30 patents

COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF MPNST

PHARMACEUTICAL COMBINATION COMPRISING TNO155 AND NAZARTINIB

Dosing schedule of a Wnt inhibitor and an anti-PD-1 antibody molecu...

NEW THERAPEUTIC USES

THERAPEUTIC COMBINATION OF A THIRD-GENERATION EGFR TYROSINE KINASE...

THERAPEUTIC COMBINATION OF A THIRD GENERATION EGFR TYROSINE KINASE...

DOSING SCHEDULE OF A WNT INHIBITOR AND AN ANTI-PD-1 ANTIBODY MOLECU...